AU2001271037A1 - Pharmaceutical compositions containing dds compounds - Google Patents
Pharmaceutical compositions containing dds compoundsInfo
- Publication number
- AU2001271037A1 AU2001271037A1 AU2001271037A AU7103701A AU2001271037A1 AU 2001271037 A1 AU2001271037 A1 AU 2001271037A1 AU 2001271037 A AU2001271037 A AU 2001271037A AU 7103701 A AU7103701 A AU 7103701A AU 2001271037 A1 AU2001271037 A1 AU 2001271037A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- dds compounds
- containing dds
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000213083 | 2000-07-13 | ||
JP2000-213083 | 2000-07-13 | ||
PCT/JP2001/006020 WO2002005855A1 (en) | 2000-07-13 | 2001-07-11 | Pharmaceutical compositions containing dds compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001271037A1 true AU2001271037A1 (en) | 2002-01-30 |
Family
ID=18708899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001271037A Abandoned AU2001271037A1 (en) | 2000-07-13 | 2001-07-11 | Pharmaceutical compositions containing dds compounds |
Country Status (12)
Country | Link |
---|---|
US (1) | US6815435B2 (en) |
EP (1) | EP1308171A1 (en) |
KR (1) | KR20030023697A (en) |
CN (1) | CN1556712A (en) |
AR (1) | AR031714A1 (en) |
AU (1) | AU2001271037A1 (en) |
BR (1) | BR0112417A (en) |
CA (1) | CA2415922A1 (en) |
MX (1) | MXPA03000387A (en) |
NO (1) | NO20030139L (en) |
RU (1) | RU2003100532A (en) |
WO (1) | WO2002005855A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030166513A1 (en) * | 2000-06-29 | 2003-09-04 | Akihiro Imura | Dds compound and process for the preparation thereof |
TWI320713B (en) | 2001-06-01 | 2010-02-21 | Neochemir Inc | |
TW200306314A (en) * | 2002-04-16 | 2003-11-16 | Tanabe Seiyaku Co | Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation |
KR20090091365A (en) * | 2002-12-10 | 2009-08-27 | 네오케미아 가부시키가이샤 | Skin material for external use, and antipruritic agent for external use and wrinkle-reducing instrument using the same |
TW200727900A (en) * | 2005-07-27 | 2007-08-01 | Yakult Honsha Kk | Aqueous solution preparation containing camptothecins |
JO3112B1 (en) | 2010-03-29 | 2017-09-20 | Ferring Bv | A fast dissolving pharmaceutical composition |
AU2013263795B2 (en) * | 2010-03-29 | 2015-09-17 | Ferring B.V. | A fast dissolving pharmaceutical composition |
CN102834091B (en) | 2010-03-29 | 2015-04-22 | 辉凌公司 | A fast dissolving pharmaceutical composition |
NZ620897A (en) | 2011-09-16 | 2016-07-29 | Ferring Bv | A fast dissolving pharmaceutical composition |
KR102417310B1 (en) | 2012-10-11 | 2022-07-05 | 다이이찌 산쿄 가부시키가이샤 | Method for producing a glycinamide compound |
US9872924B2 (en) | 2012-10-19 | 2018-01-23 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
KR102088169B1 (en) | 2013-12-25 | 2020-03-12 | 다이이찌 산쿄 가부시키가이샤 | Anti-trop2 antibody-drug conjugate |
CN110464847B (en) | 2014-01-31 | 2024-02-09 | 第一三共株式会社 | anti-HER 2 antibody-drug conjugates |
KR102445502B1 (en) | 2014-04-10 | 2022-09-21 | 다이이찌 산쿄 가부시키가이샤 | Anti-her3 antibody-drug conjugate |
EP3130608B1 (en) | 2014-04-10 | 2019-09-04 | Daiichi Sankyo Co., Ltd. | (anti-her2 antibody)-drug conjugate |
AU2015369185B2 (en) | 2014-12-26 | 2020-10-22 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical preparation of camptothecin-containing polymer derivative |
BR112017027690A2 (en) | 2015-06-29 | 2018-10-09 | Daiichi Sankyo Co Ltd | “method for producing an antibody-drug conjugate composition, and antibody-drug conjugate composition |
CA2995053A1 (en) | 2015-09-03 | 2017-03-09 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical composition containing camptothecin polymer derivative |
CA3015459A1 (en) | 2016-03-01 | 2017-09-08 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical preparation containing camptothecin-based polymeric derivative |
CA3046293A1 (en) | 2016-12-12 | 2018-06-21 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and immune checkpoint inhibitor |
TWI780104B (en) | 2017-01-17 | 2022-10-11 | 日商第一三共股份有限公司 | Anti gpr20 antibodies and anti gpr20 antibody-drug conjugates, as well as manufacturing method and use thereof |
TWI794230B (en) | 2017-05-15 | 2023-03-01 | 日商第一三共股份有限公司 | Anti cdh6 antibodies and anti cdh6 antibody drug conjugates, as well as manufacturing method thereof |
EP3677568A4 (en) | 2017-08-31 | 2021-05-12 | Daiichi Sankyo Company, Limited | Novel method for producing antibody-drug conjugate |
WO2019044947A1 (en) | 2017-08-31 | 2019-03-07 | 第一三共株式会社 | Improved method for producing antibody-drug conjugate |
HRP20230787T1 (en) | 2018-05-18 | 2023-10-27 | Glycotope Gmbh | Anti-muc1 antibody |
US11634508B2 (en) | 2019-07-10 | 2023-04-25 | Cybrexa 2, Inc. | Peptide conjugates of cytotoxins as therapeutics |
EP3996749A1 (en) | 2019-07-10 | 2022-05-18 | Cybrexa 3, Inc. | Peptide conjugates of microtubule-targeting agents as therapeutics |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5711909A (en) * | 1980-06-23 | 1982-01-21 | Shionogi & Co Ltd | Stable freeze-dried preparation of beta-lactam |
JPS61165322A (en) * | 1985-01-14 | 1986-07-26 | Microbial Chem Res Found | Spergualin composition for pharmaceutical use |
CN1195990A (en) | 1995-09-13 | 1998-10-14 | 日本新药株式会社 | PGE1-containing freeze-dried preparation and process for production thereof |
NZ331372A (en) * | 1996-02-19 | 2000-01-28 | Nycomed Imaging As | freeze-dried vesicle containing a thermally stabilized ultrasound contrast agent |
AU2034097A (en) * | 1996-03-19 | 1997-10-10 | Morgan Crucible Company Plc, The | A conduit |
JPH10212241A (en) | 1996-05-27 | 1998-08-11 | Sumitomo Pharmaceut Co Ltd | Preparation stably containing bdnf |
TW527183B (en) | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
WO2000018401A1 (en) | 1998-09-29 | 2000-04-06 | Takeda Chemical Industries, Ltd. | Antimycotic drug composition |
-
2001
- 2001-07-11 CA CA002415922A patent/CA2415922A1/en not_active Abandoned
- 2001-07-11 MX MXPA03000387A patent/MXPA03000387A/en not_active Application Discontinuation
- 2001-07-11 AU AU2001271037A patent/AU2001271037A1/en not_active Abandoned
- 2001-07-11 WO PCT/JP2001/006020 patent/WO2002005855A1/en active Application Filing
- 2001-07-11 CN CNA018153607A patent/CN1556712A/en active Pending
- 2001-07-11 BR BR0112417-0A patent/BR0112417A/en not_active Application Discontinuation
- 2001-07-11 US US10/332,706 patent/US6815435B2/en not_active Expired - Fee Related
- 2001-07-11 RU RU2003100532/15A patent/RU2003100532A/en not_active Application Discontinuation
- 2001-07-11 KR KR10-2003-7000380A patent/KR20030023697A/en not_active Application Discontinuation
- 2001-07-11 EP EP01949945A patent/EP1308171A1/en not_active Withdrawn
- 2001-07-12 AR ARP010103302A patent/AR031714A1/en unknown
-
2003
- 2003-01-10 NO NO20030139A patent/NO20030139L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20030148931A1 (en) | 2003-08-07 |
RU2003100532A (en) | 2004-07-20 |
US6815435B2 (en) | 2004-11-09 |
CA2415922A1 (en) | 2002-01-24 |
MXPA03000387A (en) | 2003-09-22 |
KR20030023697A (en) | 2003-03-19 |
WO2002005855A1 (en) | 2002-01-24 |
NO20030139D0 (en) | 2003-01-10 |
EP1308171A1 (en) | 2003-05-07 |
BR0112417A (en) | 2003-07-01 |
NO20030139L (en) | 2003-03-13 |
CN1556712A (en) | 2004-12-22 |
AR031714A1 (en) | 2003-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001271037A1 (en) | Pharmaceutical compositions containing dds compounds | |
AU781269C (en) | Pharmaceutical compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2002222118A1 (en) | Pharmaceutical compositions for inhalation | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU1071301A (en) | Pharmaceutical compounds | |
AU2002363361A1 (en) | Pharmaceutical compositions containing oxybutynin | |
IL148864A0 (en) | Pharmaceutical compositions containing nimesulide | |
AU2002217464A1 (en) | Medicinal compositions containing aspirin | |
AU2002302147A1 (en) | Pharmaceutical composition | |
AU3556400A (en) | Pharmaceutical compositions | |
AU1574900A (en) | Pharmaceutical compositions containing insulin | |
AU2001262733A1 (en) | Medicinal compositions containing propenone derivatives | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2002221115A1 (en) | Medicinal compositions having improved absorbability | |
HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
AU6370299A (en) | Pharmaceutical compositions containing tetrahydroisoquinoline compounds | |
AU4304400A (en) | Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU6460400A (en) | Pharmaceutical compositions | |
AU7937500A (en) | Pharmaceutical composition containing midazolam | |
AU2002215114A1 (en) | Pharmaceutical compositions for inhalation | |
AU6460200A (en) | Pharmaceutical compositions | |
AU5722900A (en) | Pharmaceutical compounds | |
AU4085201A (en) | Pharmaceutical composition |